 Lyndsey DuBose
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Stiffness | 16 | 2024 | 493 | 3.350 |
Why?
| | Aging | 12 | 2025 | 1864 | 1.360 |
Why?
| | Vascular Diseases | 2 | 2022 | 244 | 1.150 |
Why?
| | Testosterone | 4 | 2025 | 401 | 1.150 |
Why?
| | Cardiorespiratory Fitness | 4 | 2024 | 55 | 1.150 |
Why?
| | White Matter | 3 | 2024 | 145 | 1.010 |
Why?
| | Carotid Arteries | 7 | 2024 | 209 | 0.990 |
Why?
| | Hypogonadism | 1 | 2024 | 88 | 0.860 |
Why?
| | Cerebrovascular Circulation | 3 | 2022 | 241 | 0.830 |
Why?
| | Menopause | 2 | 2023 | 319 | 0.800 |
Why?
| | Endothelium, Vascular | 8 | 2025 | 927 | 0.770 |
Why?
| | Perimenopause | 1 | 2023 | 63 | 0.770 |
Why?
| | Hypercapnia | 1 | 2022 | 53 | 0.760 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2022 | 204 | 0.740 |
Why?
| | Pulse Wave Analysis | 9 | 2024 | 269 | 0.660 |
Why?
| | Vasodilation | 5 | 2025 | 496 | 0.620 |
Why?
| | Brachial Artery | 5 | 2025 | 201 | 0.600 |
Why?
| | Cognitive Dysfunction | 2 | 2022 | 385 | 0.580 |
Why?
| | Memory, Short-Term | 2 | 2020 | 255 | 0.570 |
Why?
| | Blood Flow Velocity | 2 | 2022 | 412 | 0.560 |
Why?
| | Educational Status | 1 | 2019 | 484 | 0.540 |
Why?
| | Cognition | 4 | 2021 | 1169 | 0.530 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2019 | 176 | 0.510 |
Why?
| | Aorta, Thoracic | 1 | 2018 | 267 | 0.490 |
Why?
| | Pre-Eclampsia | 3 | 2023 | 189 | 0.480 |
Why?
| | Cardiovascular Diseases | 6 | 2024 | 2113 | 0.480 |
Why?
| | Executive Function | 1 | 2019 | 448 | 0.460 |
Why?
| | Blood Pressure | 8 | 2023 | 1776 | 0.370 |
Why?
| | Arterial Pressure | 2 | 2023 | 125 | 0.340 |
Why?
| | Middle Aged | 20 | 2025 | 33310 | 0.340 |
Why?
| | Aorta | 4 | 2021 | 417 | 0.330 |
Why?
| | Aged | 16 | 2025 | 23851 | 0.330 |
Why?
| | Oxidative Stress | 3 | 2024 | 1315 | 0.290 |
Why?
| | Sympathetic Nervous System | 2 | 2019 | 182 | 0.290 |
Why?
| | Exercise | 4 | 2024 | 2045 | 0.280 |
Why?
| | Hippocampus | 2 | 2024 | 895 | 0.260 |
Why?
| | Humans | 31 | 2025 | 137294 | 0.250 |
Why?
| | Female | 21 | 2024 | 73052 | 0.250 |
Why?
| | Magnetic Resonance Imaging | 5 | 2024 | 3568 | 0.230 |
Why?
| | Baroreflex | 2 | 2022 | 57 | 0.230 |
Why?
| | Pregnancy Trimester, Third | 2 | 2023 | 114 | 0.220 |
Why?
| | Male | 20 | 2025 | 67560 | 0.210 |
Why?
| | Atrophy | 1 | 2024 | 184 | 0.210 |
Why?
| | Endothelin-1 | 1 | 2025 | 182 | 0.210 |
Why?
| | Estrogens | 2 | 2023 | 368 | 0.200 |
Why?
| | Progesterone | 1 | 2024 | 254 | 0.200 |
Why?
| | Peroxynitrous Acid | 1 | 2022 | 13 | 0.200 |
Why?
| | Estradiol | 2 | 2024 | 518 | 0.200 |
Why?
| | Aged, 80 and over | 5 | 2024 | 7607 | 0.200 |
Why?
| | Adult | 15 | 2025 | 37724 | 0.190 |
Why?
| | Mentors | 1 | 2023 | 199 | 0.180 |
Why?
| | Vascular Remodeling | 2 | 2023 | 189 | 0.180 |
Why?
| | Acceptance and Commitment Therapy | 1 | 2021 | 27 | 0.180 |
Why?
| | Brain | 3 | 2024 | 2675 | 0.180 |
Why?
| | Nitric Oxide Synthase | 1 | 2021 | 240 | 0.180 |
Why?
| | Age Factors | 4 | 2025 | 3297 | 0.180 |
Why?
| | Nitric Oxide | 2 | 2023 | 915 | 0.170 |
Why?
| | Hyperemia | 1 | 2020 | 49 | 0.170 |
Why?
| | Peroneal Nerve | 1 | 2019 | 19 | 0.160 |
Why?
| | Physical Conditioning, Human | 1 | 2020 | 41 | 0.160 |
Why?
| | Receptor, Endothelin B | 1 | 2019 | 51 | 0.160 |
Why?
| | Association Learning | 1 | 2019 | 60 | 0.150 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 66 | 0.150 |
Why?
| | Young Adult | 6 | 2024 | 13163 | 0.140 |
Why?
| | Students | 1 | 2023 | 626 | 0.140 |
Why?
| | Androgens | 1 | 2019 | 187 | 0.140 |
Why?
| | Carotid Intima-Media Thickness | 3 | 2023 | 91 | 0.140 |
Why?
| | Compliance | 1 | 2017 | 49 | 0.130 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5436 | 0.130 |
Why?
| | Trans Fatty Acids | 1 | 2016 | 6 | 0.130 |
Why?
| | Soybean Oil | 1 | 2016 | 14 | 0.130 |
Why?
| | Plant Oils | 1 | 2016 | 32 | 0.130 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 295 | 0.130 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2019 | 445 | 0.130 |
Why?
| | Beverages | 1 | 2016 | 69 | 0.130 |
Why?
| | Alzheimer Disease | 1 | 2022 | 559 | 0.120 |
Why?
| | Frontal Lobe | 1 | 2017 | 151 | 0.120 |
Why?
| | Risk Factors | 6 | 2024 | 10368 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2019 | 1709 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5125 | 0.080 |
Why?
| | Body Mass Index | 1 | 2017 | 2373 | 0.070 |
Why?
| | Pregnancy | 3 | 2023 | 6743 | 0.060 |
Why?
| | Retrospective Studies | 2 | 2023 | 15639 | 0.060 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2023 | 56 | 0.050 |
Why?
| | Cerebrovascular Disorders | 1 | 2024 | 96 | 0.050 |
Why?
| | Carotid Artery, Common | 1 | 2023 | 37 | 0.050 |
Why?
| | Lead | 1 | 2023 | 63 | 0.050 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 244 | 0.050 |
Why?
| | Adolescent | 4 | 2024 | 21499 | 0.050 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2023 | 130 | 0.050 |
Why?
| | Memory | 1 | 2024 | 255 | 0.050 |
Why?
| | Writing | 1 | 2023 | 94 | 0.050 |
Why?
| | omega-N-Methylarginine | 1 | 2021 | 27 | 0.050 |
Why?
| | Plethysmography | 1 | 2022 | 106 | 0.050 |
Why?
| | Elastin | 1 | 2021 | 78 | 0.050 |
Why?
| | Career Choice | 1 | 2023 | 216 | 0.050 |
Why?
| | Inflammation | 2 | 2023 | 2836 | 0.050 |
Why?
| | Ultrasonography, Doppler | 1 | 2022 | 123 | 0.040 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2021 | 85 | 0.040 |
Why?
| | Cerebral Cortex | 1 | 2024 | 434 | 0.040 |
Why?
| | Learning | 1 | 2024 | 415 | 0.040 |
Why?
| | Arterioles | 1 | 2020 | 52 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2020 | 79 | 0.040 |
Why?
| | Biomarkers | 2 | 2025 | 4164 | 0.040 |
Why?
| | Blood Pressure Determination | 1 | 2020 | 156 | 0.040 |
Why?
| | Collagen | 1 | 2021 | 446 | 0.040 |
Why?
| | Regional Blood Flow | 1 | 2020 | 474 | 0.040 |
Why?
| | Organ Size | 1 | 2019 | 477 | 0.040 |
Why?
| | Antioxidants | 1 | 2022 | 586 | 0.040 |
Why?
| | Heart Rate | 1 | 2022 | 823 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 2021 | 374 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 778 | 0.040 |
Why?
| | Femoral Artery | 1 | 2019 | 179 | 0.040 |
Why?
| | Reaction Time | 1 | 2019 | 416 | 0.030 |
Why?
| | Coconut Oil | 1 | 2016 | 3 | 0.030 |
Why?
| | Iowa | 1 | 2016 | 30 | 0.030 |
Why?
| | Nitrites | 1 | 2016 | 84 | 0.030 |
Why?
| | Nitrates | 1 | 2016 | 92 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2023 | 3546 | 0.030 |
Why?
| | Postprandial Period | 1 | 2016 | 107 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2071 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 1055 | 0.030 |
Why?
| | Anxiety | 1 | 2021 | 1036 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2016 | 562 | 0.030 |
Why?
| | Administration, Oral | 1 | 2016 | 812 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2073 | 0.030 |
Why?
| | Hypertension | 1 | 2020 | 1285 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 7595 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2016 | 1203 | 0.020 |
Why?
| | Time Factors | 1 | 2016 | 6818 | 0.020 |
Why?
|
|
DuBose's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|